Sheng Lin

Sheng Lin


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2022 in Redox Biology
Verified
Journal Article
Open access
MSMeng Song
Meng Song
ZCZijun Chen
Zijun Chen
RQRuian Qiu
Ruian Qiu
TZTingwei Zhi
Tingwei Zhi
WXWenmin Xie
Wenmin Xie
CLChanghui Liu
Changhui Liu
The excessive accumulation of bile acids (BA) in hepatocytes can trigger inflammatory response and recruit macrophages, thereby accelerating cholestatic liver injury. The crosstalk between hepatocytes and macrophages has been recently implicated in the pathogenesis of cholestasis; however, the underlying mechanisms remain unclear. Here, we demonstrated that BA initiate NLRP3 inflammasome activation in hepatocytes to release proinflammatory cytokines and promote the communication between hepatocytes and macrophages, thus enhancing liver inflammation in an NLRP3-dependent manner. NLRP3-inhibition by geniposidic acid (GPA), a novel NLRP3-specific covalent inhibitor that directly interacts with NLRP3, in hepatocytes and macrophages abated BA-induced inflammation. Moreover, NLRP3-deletion or its inhibition mitigated ANIT-induced cholestatic inflammation, whereas disrupting the crosstalk between hepatic macrophages and hepatocytes attenuated the hepatoprotective effect of GPA against ANIT-induced cholestatic inflammation. Therefore, blocking this crosstalk by suppressing NLRP3 inflammasome activation may represent a novel therapeutic strategy for cholestasis.

10 July 2012 in Journal of Natural Products
Verified
Journal Article
Closed access
MGMaoluo Gan
Maoluo Gan
MLMingtao Liu
Mingtao Liu
LGLishe Gan
Lishe Gan
SLSheng Lin
Sheng Lin
BLBo Liu
Bo Liu
JSJiangong Shi
Jiangong Shi

5 November 2018 in Organic Letters
Verified
Journal Article
Closed access
YWYa-Nan Wang
Ya-Nan Wang
GXGui-Yang Xia
Gui-Yang Xia
LWLing-Yan Wang
Ling-Yan Wang
Guang-Bo GeGuang-Bo Ge
Guang-Bo Ge
HZHua-Wei Zhang
Hua-Wei Zhang
SLSheng Lin
Sheng Lin

1 March 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YJYibing Ji
Yibing Ji
QZQian Zhang
Qian Zhang
HLHua Li
Hua Li
LCLixia Chen
Lixia Chen
YWYu-zhuo Wu
Yu-zhuo Wu
SLSheng Lin
Sheng Lin
Platelet factor 4 (PF4), also referred to as CXCL4, is a significant component of the C-X-C chemokine family, predominantly localized within the alpha granules of platelets. It is recognized for its anti-heparin and anti-angiogenic properties. However, the involvement of PF4 in inflammatory processes has not been extensively investigated. This article aims to explore the diverse functions of PF4 in the context of inflammatory diseases, emphasizing its potential dual regulatory roles across various immune cell types and pathological conditions. Recent research has enhanced our comprehension of PF4, revealing its production not only in platelets but also in macrophages and activated T cells, thereby extending its functional repertoire beyond its conventional roles. Consequently, this review provides a thorough analysis of PF4’s influence on inflammatory diseases and offers perspectives and recommendations for future research endeavors.

1 February 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YWYu-Zhuo Wu
Yu-Zhuo Wu
HZHua-Wei Zhang
Hua-Wei Zhang
ZSZhao-Hui Sun
Zhao-Hui Sun
JDJun-Gui Dai
Jun-Gui Dai
YHYou-Cai Hu
You-Cai Hu
SLSheng Lin
Sheng Lin

25 May 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
LWLing-Yan Wang
Ling-Yan Wang
MCMing-Hua Chen
Ming-Hua Chen
Jiang WuJiang Wu
Jiang Wu
HSHua Sun
Hua Sun
WLWei Liu
Wei Liu
SLSheng Lin
Sheng Lin